August 31, 2020
August 31, 2020 – The U.S. FDA has approved Xaracoll® (bupivacaine HCl), an implant manufactured by
Innocoll Pharmaceuticals, to provide acute postsurgical pain relief for up to 24 hours
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health
August 31, 2020
August 31, 2020 – Mylan and Biocon Biologics have launched SemgleeTM (insulin glargine injection) in vial
and pre-filled pen dosage forms. The product is FDA-approved to help control blood sugar
August 28, 2020
August 28, 2020 – The U.S. FDA has expanded its Emergency Use Authorization (EUA) for the investigational drug Veklury® (remdesivir), manufactured by Gilead. While not
August 28, 2020
August 28, 2020 – The U.S. FDA has approved Sogroya® (somapacitan-beco) injection 10mg/1.5mL
(6.7mg/mL), manufactured by Novo Nordisk, for the replacement of endogenous
August 27, 2020
August 27, 2020 – The U.S. FDA has approved Winlevi® (clascoterone cream 1%), manufactured by Cosmo Pharmaceuticals, to treat acne vulgaris in patients who are at least 12 years of age
August 27, 2020
August 27, 2020 – The U.S. FDA has approved an expanded indication for Ultravate® (halobetasol
propionate) topical lotion, manufactured by Sun Pharmaceuticals. The product can now
August 26, 2020
August 26, 2020 – The U.S. FDA has removed a black box warning for canagliflozin-containing products
regarding an increased risk of amputation. The warning was originally added to the drugs
August 25, 2020
August 25, 2020 – The U.S. FDA has approved Cystadrops® (cysteamine ophthalmic solution) 0.37%, manufactured by Recordati Rare Diseases, to treat corneal cystine crystal deposits in